B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to wipe out leukemia without lifelong drugs
Disease control Recruiting nowThis study tests a new treatment plan for people aged 15 to 65 with a type of blood cancer called B-cell acute lymphoblastic leukemia. The plan combines a reduced dose of chemotherapy with an immunotherapy drug called blinatumomab, followed by more chemo and possibly a stem cell …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 16, 2026 20:17 UTC
-
New enzyme combo aims to boost leukemia treatment in High-Risk adults
Disease control Recruiting nowThis study tests whether a new form of the drug asparaginase (made from a different bacterium) can be safely combined with standard chemotherapy for high-risk adults aged 18–54 with newly diagnosed acute lymphoblastic leukemia or lymphoblastic lymphoma. The treatment aims to kill…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New combo therapy offers hope for Hard-to-Treat leukemia
Disease control Recruiting nowThis study combines a targeted antibody-drug (inotuzumab ozogamicin) with low-intensity chemotherapy to treat adults with acute lymphoblastic leukemia (ALL). The goal is to find the best dose and see if the combination improves survival and remission rates. Participants include o…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Double-Drug attack shows promise against Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a two-step treatment for a type of leukemia (B-ALL) in older adults or those whose cancer came back or didn't respond to prior therapy. The drugs, inotuzumab ozogamicin and blinatumomab, work like smart bombs to target and kill cancer cells. The goal is to see if…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New combo therapy targets tough leukemia in adults
Disease control Recruiting nowThis study tests a chemotherapy cocktail (DA-EPOCH) plus a drug called Rylaze in adults newly diagnosed with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The goal is to see if this combination can kill more cancer cells and achieve deep remission. About 30…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC